E Fund Management Co., Ltd. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $64,849 - $113,872	780 Added 34.53%	3,039 $443,000
Q1 2022 May 12, 2022	BUY	$110.08 - $142.92 $57,241 - $74,318	520 Added 29.9%	2,259 $268,000
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $3,889 - $5,790	39 Added 2.29%	1,739 $240,000
Q1 2021 May 12, 2021	BUY	$64.07 - $91.75 $108,918 - $155,975	1,700 New	1,700 $116,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.